Baker Bros. Advisors LP Sangamo Therapeutics, Inc Transaction History

Baker Bros. Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$10.17 - $12.64 $4.36 Million - $5.42 Million	-429,063 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $4.66 Million - $7.3 Million	-428,276 Reduced 49.95%	429,063 $5.38 Million
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $853,627 - $1.68 Million	-92,484 Reduced 9.74%	857,339 $13.4 Million
Q3 2020 Nov 16, 2020	SELL	$9.38 - $12.48 $469,000 - $624,000	-50,000 Reduced 5.0%	949,823 $8.98 Million
Q4 2018 Feb 13, 2019	SELL	$9.51 - $16.6 $2.7 Million - $4.72 Million	-284,100 Reduced 22.13%	999,823 $11.5 Million
Q2 2018 Aug 14, 2018	SELL	$13.9 - $19.8 $4.5 Million - $6.41 Million	-323,656 Reduced 20.13%	1,283,923 $18.2 Million
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $8.45 Million - $13.3 Million	-505,797 Reduced 23.93%	1,607,579 $30.5 Million
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $17.8 Million - $31.7 Million	2,113,376	2,113,376 $31.7 Million

133

86.3M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $136M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.